Shristi Rawal1,2, Michael Y Tsai3, Stefanie N Hinkle1, Yeyi Zhu4, Wei Bao5, Yuan Lin1, Pranati Panuganti1, Paul S Albert6, Ronald C W Ma7, Cuilin Zhang1. 1. Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. 2. Department of Nutritional Sciences, School of Health Professions, Rutgers University, Newark, New Jersey. 3. Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota. 4. Division of Research, Kaiser Permanente Northern California, Oakland, California. 5. Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa. 6. Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. 7. Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.
Abstract
Context: T3 is the biologically active thyroid hormone involved in glucose metabolism. The free T3 (fT3)/free T4 (fT4) ratio, a marker indicating conversion of fT4 to fT3, is also implicated in glucose homeostasis. Objective: To examine associations of fT3 and the fT3/fT4 ratio with gestational diabetes mellitus (GDM). Design: In a case-control study, thyroid markers (fT3, fT4, TSH) were measured and the fT3/fT4 ratio was derived across four visits in pregnancy, including first (gestational weeks 10 to 14) and second (weeks 15 to 26) trimester. Conditional logistic regression adjusting for thyroid autoimmunity status and major GDM risk factors estimated trimester-specific associations of thyroid markers with subsequent GDM risk. Setting: Twelve US clinical centers. Participants: One hundred seven GDM cases and 214 non-GDM controls from a multiracial pregnancy cohort of 2802 women. Main Outcome Measures: GDM diagnosis ascertained from medical records. Results: Both fT3 and the fT3/fT4 ratio were positively associated with GDM: adjusted OR (95% CI) comparing the highest vs lowest fT3 quartile was 4.25 (1.67, 10.80) at the first trimester and 3.89 (1.50, 10.10) at the second trimester. Similarly, the corresponding risk estimates for the fT3/fT4 ratio were 8.63 (2.87, 26.00) and 13.60 (3.97, 46.30) at the first and second trimester, respectively. Neither TSH nor fT4 was significantly associated with GDM. Conclusions: Higher fT3 levels, potentially resulting from de novo synthesis or increased fT4 to fT3 conversion, may be an indicator of GDM risk starting early in pregnancy.
Context: T3 is the biologically active thyroid hormone involved in glucose metabolism. The free T3 (fT3)/free T4 (fT4) ratio, a marker indicating conversion of fT4 to fT3, is also implicated in glucose homeostasis. Objective: To examine associations of fT3 and the fT3/fT4 ratio with gestational diabetes mellitus (GDM). Design: In a case-control study, thyroid markers (fT3, fT4, TSH) were measured and the fT3/fT4 ratio was derived across four visits in pregnancy, including first (gestational weeks 10 to 14) and second (weeks 15 to 26) trimester. Conditional logistic regression adjusting for thyroid autoimmunity status and major GDM risk factors estimated trimester-specific associations of thyroid markers with subsequent GDM risk. Setting: Twelve US clinical centers. Participants: One hundred seven GDM cases and 214 non-GDM controls from a multiracial pregnancy cohort of 2802 women. Main Outcome Measures: GDM diagnosis ascertained from medical records. Results: Both fT3 and the fT3/fT4 ratio were positively associated with GDM: adjusted OR (95% CI) comparing the highest vs lowest fT3 quartile was 4.25 (1.67, 10.80) at the first trimester and 3.89 (1.50, 10.10) at the second trimester. Similarly, the corresponding risk estimates for the fT3/fT4 ratio were 8.63 (2.87, 26.00) and 13.60 (3.97, 46.30) at the first and second trimester, respectively. Neither TSH nor fT4 was significantly associated with GDM. Conclusions: Higher fT3 levels, potentially resulting from de novo synthesis or increased fT4 to fT3 conversion, may be an indicator of GDM risk starting early in pregnancy.
Authors: Erik K Alexander; Elizabeth N Pearce; Gregory A Brent; Rosalind S Brown; Herbert Chen; Chrysoula Dosiou; William A Grobman; Peter Laurberg; John H Lazarus; Susan J Mandel; Robin P Peeters; Scott Sullivan Journal: Thyroid Date: 2017-03 Impact factor: 6.568
Authors: Germaine M Buck Louis; Jagteshwar Grewal; Paul S Albert; Anthony Sciscione; Deborah A Wing; William A Grobman; Roger B Newman; Ronald Wapner; Mary E D'Alton; Daniel Skupski; Michael P Nageotte; Angela C Ranzini; John Owen; Edward K Chien; Sabrina Craigo; Mary L Hediger; Sungduk Kim; Cuilin Zhang; Katherine L Grantz Journal: Am J Obstet Gynecol Date: 2015-10 Impact factor: 8.661
Authors: James E Haddow; Wendy Y Craig; Louis M Neveux; Glenn E Palomaki; Geralyn Lambert-Messerlian; Fergal D Malone; Mary E D'Alton Journal: PLoS One Date: 2016-02-24 Impact factor: 3.240
Authors: Sebastián Gutiérrez-Vega; Axel Armella; Daniela Mennickent; Marco Loyola; Ambart Covarrubias; Bernel Ortega-Contreras; Carlos Escudero; Marcelo Gonzalez; Martín Alcalá; María Del Pilar Ramos; Marta Viana; Erica Castro; Andrea Leiva; Enrique Guzmán-Gutiérrez Journal: PLoS One Date: 2020-11-24 Impact factor: 3.240
Authors: Rahel L Birru; Hai-Wei Liang; Fouzia Farooq; Megha Bedi; Maisa Feghali; Catherine L Haggerty; Dara D Mendez; Janet M Catov; Carla A Ng; Jennifer J Adibi Journal: Environ Health Date: 2021-05-22 Impact factor: 7.123